Crocs, Inc. - Common Stock (NQ:CROX)

119.50 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Crocs, Inc. - Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

40 41 Next >

Crocs Poised For Negative Earnings Revision On Over-Inventoried Footwear Channel & Weak Sales Momentum: Analyst Downgrades ↗

September 07, 2023

B.Riley Securities analyst Jeff Lick downgraded Crocs Inc (NASDAQ: CROX) to Neutral from Buy at a lowered

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗

September 07, 2023

Via Benzinga

Is Crocs Stock a Buy Now? ↗

August 23, 2023

Crocs continues to perform well, and it's trading at an attractive value, too.

Via The Motley Fool

Is the Crocs Growth Story Fading? 3 Things to Know Before You Buy the Stock ↗

August 03, 2023

The Crocs brand is soaring, but HeyDude is going through growing pains.

Via The Motley Fool

Is This Unstoppable Growth Stock a Screaming Buy Right Now? ↗

August 02, 2023

This booming footwear business should be on your radar.

Via The Motley Fool

Roku To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday ↗

September 07, 2023

Needham cut the price target for Verint Systems Inc. (NASDAQ: VRNT) from $50 to $40. Needham analyst Ryan MacDonald maintained a Buy rating. Verint shares fell 17.8% to $25.35 in pre-market trading.

Via Benzinga

Retailers Raise Red Flags; Analysts Turn Cautious Amid Divergent Results; Lululemon, Dollar Tree, More To Report ↗

August 24, 2023

Retailers raise red flags on softer consumer spending with the slew of mixed results this earnings season. Analysts to reassess retail stocks.

Via Investor's Business Daily

3 Stocks to Buy BEFORE They Become Wall Street Darlings ↗

August 23, 2023

These are the top stocks to buy before smart money pours into these high-growth businesses with massive addressable markets.

Via InvestorPlace

10 Consumer Discretionary Stocks Whale Activity In Today's Session ↗

August 21, 2023

Via Benzinga

Crocs Inc Favors Corrective Pullback Before Rally Resumes ↗

July 31, 2023

Crocs Inc., designs, manufactures, markets & distributes casual lifestyle footwear & accessories for men, women & children worldwide.

Via Talk Markets

Crocs (CROX) Q2 2023 Earnings Call Transcript ↗

July 27, 2023

CROX earnings call for the period ending June 30, 2023.

Via The Motley Fool

Why Crocs Shares Are Falling Today ↗

July 27, 2023

Crocs Inc (NASDAQ: CROX) reported

Via Benzinga

Over $11M Bet On Impinj? Check Out These 3 Stocks Insiders Are Buying ↗

August 21, 2023

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Via Benzinga

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session ↗

August 15, 2023

Via Benzinga

3 Stocks That Are Absurdly Cheap Right Now ↗

August 15, 2023

These three stocks are trading at cheap valuations.

Via The Motley Fool

On Running Sprints To Buy Range With Earnings Due; Up 101% In 2023 ↗

August 14, 2023

On Running reports Q2 results early Tuesday as ONON stock sprinted 101% higher this year.

Via Investor's Business Daily

Jim Cramer Likes This Popular Footwear Company: 'But I Worry About The Fad Aspect' ↗

August 09, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Crocs, Inc.

Via Benzinga

Over $20M Bet On This US Energy Giant? Check Out These 3 Stocks Insiders Are Buying ↗

August 04, 2023

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

Crocs Stock: 2 Green Flags Investors Are Missing ↗

August 04, 2023

There are good reasons to try this stock on for size.

Via The Motley Fool

Foot Locker Stock: Buy, Sell or Hold? ↗

August 03, 2023

Sales are down for this athletic apparel retailer, but so is the stock's valuation.

Via The Motley Fool

7 Value-Growth Stocks That’ll Make You a Millionaire by 2025 ↗

August 02, 2023

These value-growth stocks offer the best of both worlds, with a large margin of safety and substantial upside potential.

Via InvestorPlace

Over $2M Bet On Akero Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

August 02, 2023

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

Crocs Stock Steps Up With A Rising Relative Strength Upgrade ↗

July 31, 2023

On Monday, Crocs stock got a positive adjustment to its Relative Strength (RS) Rating to 78, up from 67 a day earlier.

Via Investor's Business Daily

Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review ↗

July 28, 2023

Despite Thursday's downside reversal, the major indexes had a solid advance.

Via Investor's Business Daily

Why Crocs Stock Got Rocked Today ↗

July 27, 2023

With sales growing at 13% but selling for only 8.5 times earnings, Crocs stock is a screaming buy.

Via The Motley Fool

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session ↗

July 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗

July 28, 2023

Via Benzinga

11 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session ↗

July 27, 2023

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

CROX Stock Slides Ahead Of Crocs Earnings; Hoka Maker Deckers Brands, Skechers To Report ↗

July 26, 2023

Crocs, Skechers and Hoka shoes maker Deckers Brands are set to report earnings Thursday.

Via Investor's Business Daily

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.